Climb Bio (NASDAQ:CLYM) outlined its clinical development strategy and upcoming data readouts during a fireside chat at H.C. Wainwright's BioConnect Conference, with management emphasizing two ...
So good morning, and thank you for joining Cynata Therapeutics Investor Webinar for the December 2025 quarter. Presenting this morning will be CEO and Managing Director, Dr. Kilian Kelly, who will ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results